title: Retinal and Choroidal Haemorrhage after Tissue Plasminogen Activator Administration.
authors.affiliation: 1Department of Medicine,Dalhousie UniversityHalifax,Nova Scotia,Canada.
authors.forename: Scott
authors.initials: S
authors.lastname: Lee
authors.affiliation: 2Department of Ophthalmology and Visual Sciences,Dalhousie UniversityHalifax,Nova Scotia,Canada.
authors.forename: Harald
authors.initials: H
authors.lastname: Gjerde
authors.affiliation: 3Assistant Professor, Division of Neurology,Department of Medicine,Dalhousie University,Halifax,Nova Scotia,Canada.
authors.forename: Gordon
authors.initials: G
authors.lastname: Gubitz
mesh_terms: D000369:Aged, 80 and over; D002832:Choroid Hemorrhage / Q000139:chemically induced*; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006801:Humans; D012166:Retinal Hemorrhage / Q000139:chemically induced*; D020521:Stroke / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator
keywords: Ischemic stroke; choroidal haemorrhage; computed tomography; retinal haemorrhage; thrombolysis; tissue plasminogen activator